Ex parte GANTE et al. - Page 10


                 Appeal No.  2000-0600                                                          Page 10                   
                 Application No.  08/642,268                                                                              
                                Even if some of the claimed combinations were inoperative,                                
                                the claims are not necessarily invalid.  “It is not a function of the                     
                                claims to specifically exclude ... possible inoperative                                   
                                substances....”  In re Dinh-Nguyen, 492 F.2d 856, 859-59, 181                             
                                USPQ 46, 48 (CCPA 1974)(emphasis omitted).  Accord, In re                                 
                                Geerdes, 491 F.2d 1260, 1265, 180 USPQ 789, 793 (CCPA                                     
                                1974); In re Anderson, 471 F.2d 1237, 1242, 176 USPQ 331,                                 
                                334-35 (CCPA 1971).  Of course, if the number of inoperative                              
                                combinations becomes significant, and in effect forces one of                             
                                ordinary skill in the art to experiment unduly in order to practice                       
                                the claimed invention, the claims might indeed be invalid.  See                           
                                e.g., In re Cook, 439 F.2d 730, 735, 169 USPQ 298, 302                                    
                                (CCPA 1971).                                                                              
                 On this record, the examiner failed to provide evidence demonstrating that the                           
                 number of inoperative combinations is significant enough to force one of ordinary                        
                 skill in the art to experiment unduly in order to practice the claimed invention.                        
                         The examiner also finds (Answer, pages 4-5) “[t]he level of undesirable                          
                 integrin binding is not synonymous with doses of specific drugs needed for                               
                 administration to treat a specific disease but rather the underlying physiological                       
                 contributing factor that may lead to one or more diseases that is present in the host                    
                 and this quantity is never defined.”  In response appellants argue (Reply Brief, page                    
                 3) that “one of skill in the art would known that ‘undesired integrin binding’ is an                     
                 amount of binding which results in disease symptoms, e.g., the disease recited in                        
                 the specification, so the term is not indefinite.”  We agree.                                            
                         Furthermore, appellants argue (Brief, page 4) that “the ‘effective’ amount of                    
                 an agent required to inhibit an integrin is the amount of the agent which, in fact, does                 
                 inhibit the interaction of an integrin with its receptor and/or ligand.  Since the amount                
                 which provides such activity can be readily determine by one of ordinary skill in the                    
                 art, the meaning of ‘effective amount’ is known.”  Again, we agree with appellants.                      






Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007